Authors: Kulkarni, R Aledort, LM Berntorp, E Brackman, HH Brown, D Cohen, AR Ewing, NP Gringeri, A Gruppo, R Hoots, K Leissenger, C Peerlinck, K Poon, MC Wong, WY

Citation: R. Kulkarni et al., Therapeutic choices for patients with hemophilia and high-titer inhibitors, AM J HEMAT, 67(4), 2001, pp. 240-246

Authors: Gao, XJ Nelson, GW Karacki, P Martin, MP Phair, J Kaslow, R Goedert, JJ Buchbinder, S Hoots, K Vlahov, D O'Brien, SJ Carrington, M

Citation: Xj. Gao et al., Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS., N ENG J MED, 344(22), 2001, pp. 1668-1675

Authors: Abshire, TC Brackmann, HH Scharrer, I Hoots, K Gazengel, C Powell, JS Gorina, E Kellermann, E Vosburgh, E

Citation: Tc. Abshire et al., Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - Results of a multicenter, international, clinical investigation, THROMB HAEM, 83(6), 2000, pp. 811-816

Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M

Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137

Authors: Daar, ES Lynn, H Donfield, S Gomperts, E Hilgartner, MW Hoots, K Chernoff, D Winkler, C O'Brien, SJ

Citation: Es. Daar et al., Effects of plasma HIV RNA, CD4(+) T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs, J ACQ IMM D, 21(4), 1999, pp. 317-325

Authors: Carrington, M Nelson, GW Martin, MP Kissner, T Vlahov, D Goedert, JJ Kaslow, R Buchbinder, S Hoots, K O'Brien, SJ

Citation: M. Carrington et al., HLA and HIV-1: Heterozygote advantage and B35-Cw*04 disadvantage, SCIENCE, 283(5408), 1999, pp. 1748-1752